A hearty good morning, bonjour, and JonBonJovi to you all, and welcome to Thursday morning’s pre-market madness… which – after yesterday’s annoyingly disappointing result – will hopefully pan out heaps better for all of us, as the relentless tide of time carries us forward once more.

We’ve got a bunch of stuff for you to sink your teeth into before the ASX rollerdoors go up for the day, including Emma Davies’ inaugural column looking at some top-notch executives looking to replicate success of their past roles with well known companies.

Nadine McGrath’s been on the phone with some leading investors to get their insights into who they reckon could be worth backing this week, and Eddy Sunarto draws back the curtains on who’s making waves in Health Care right now.

To help get you warmed up, as always we’ve all the data and digits from yesterday to give you a running start at the markets today. Bon Appetit!



Gold: US$1,891.55 (-0.53%)

Silver: US$22.41 (-0.44%)

Nickel (3mth): US$19,870/t (+0.46%)

Copper (3mth): US$8,173/t (-0.32%)

Oil (WTI): US$79.19  (-2.23%)

Oil (Brent): US$83.28 (-1.90%)

Iron 62pc Fe: US$104.81/t (+0.01%)

AUD/USD: 0.6424  (-0.5%)

Bitcoin: US$28,890.25 (-1.09%)



Health stocks have been on the rise, so naturally that’s what’s got everyone talking today…




Here are the best performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin


Yesterday’s Small Caps standouts were:

Up on top of the podium was the recently returned Loyal Lithium (ASX:LLI), which took to the skies to climb more than 45% on news of a significant development in the ongoing field where Loyal has reported the discovery of five (count ‘em… 5!) spodumene bearing pegmatite dykes with aligned implied continuous outcrops within a 6km2 area to the south of the Trieste Greenstone Belt.

Loyal says that prep work for drilling is underway, so we’ll just have to wait to see if the find is as juicy as it sounds so far.

In second place, AML3D (ASX:AL3) ended the day up 22.22% (admit it… you read that in Richie Benaud’s voice) on news of a fresh $2 million contract from the US Navy to develop and metal 3D print a replacement component used in US Navy submarines.

Obviously, we’re not able to tell you precisely which bits of the submarines are involved, but the company has said that the “non-safety-critical (NSC) components are high demand components made with Nickel-Aluminum-Bronze”.

The contract is due to run for roughly nine months from September this year, with the fee payable up-front and upon meeting contract milestones.

And in third place, Lumos Diagnostics (ASX:LDX) was back in the headlines thanks to a 21.1% jump driven by a double-dose of great news for the local biotech.

For starters, LDX has signed a deal with the Dutch subsidiary of Nasdaq-listed Henry Shein Inc – the world’s largest provider of health care solutions to office-based dental and medical practitioners – to distribute the company’s FebriDx point-of-care test that can tell a bacterial lung infection from a viral one within minutes.

Additionally, LDX has been granted a core patent in Europe and Japan, covering the camera technology used in its rapid diagnostics reader platform.

“These readers have become a critical component of new point-of-care tests as they automate the reading and quantification of results and allow those results to be seamlessly integrated into electronic medical record systems,” the company says.



Here are the worst performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin



Imugene (ASX:IMU) – Capital raising.

Sacgasco (ASX:SGC) – Update on the PNOC farm-in.

ActivePort Group (ASX:ATV) – Capital raising.

Core Lithium (ASX:CXO) – Capital raising.

Chrysos Corporation (ASX:C79) – Announcement regarding an ASX price and volume query.